The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021

(2021) Megan Wallace et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Addressing Racial and Ethnic Disparities in COVID-19 Among School-Aged Children: Are We Doing Enough?

(2021) Arica White et al.   Preventing Chronic Disease

Outbreak Associated with SARS-CoV-2 B.1.617.2 (Delta) Variant in an Elementary School — Marin County, California, May–June 2021

(2021) Tracy Lam-Hine et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021

(2021) Julia W. Gargano et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Incidence Rates, Household Infection Risk, and Clinical Characteristics of SARS-CoV-2 Infection Among Children and Adults in Utah and New York City, New York

(2021) Fatimah S. Dawood et al.   JAMA Pediatrics

Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2

(2021) Erika Molteni et al.   Lancet Child & Adolescent Health

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020

(2020) Sara E. Oliver et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT